Expression of Immunogenic Cell Death-Related Genes is Correlated with Immune Microenvironment and Predicts Prognosis in Lung Adenocarcinoma

Author:

Gong Wenlin1,Gao Fushan1,Shao Fei1,Chen Leifeng1,Gao Yibo1,He Jie1

Affiliation:

1. National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College

Abstract

Abstract Immunogenic cell death (ICD) is a type of regulated cell death that is enough to primes adaptive immune response. Mounting evidence has demonstrated that ICD has the potential to modify the tumor immune microenvironment by release of numerous damage-associated molecular patterns (DAMPs), which may contribute to the immunotherapy. We aimed to explore the expression profile of ICD-associated biomarkers and construct a prognostic signature based on these genes in Lung adenocarcinoma (LUAD). Here, we identified two ICD-associated molecular subgroups with significantly different survival. The cluster 1 presented a favorable prognosis and associated with high abundance of immune infiltrating cells and relatively high immune status. Functional analyses revealed that the Differentially Expressed Genes (DEGs) between the two subgroups were mainly enriched in immune response signaling. Besides, a risk score signature was established based on eleven ICD-related genes, the signature possessed potent potential for prognosis prediction of LUAD patients, Analysis of immune profiles showed that low-risk groups presented noticeable immune-cell infiltrations and more likely to benefit from immunotherapy. In conclusion, our research established a new classification system of LUAD based on ICD signature. This stratification had significant guide clinical practice for estimating prognosis, as well as the potential immunotherapy for LUAD patients.

Publisher

Research Square Platform LLC

Reference55 articles.

1. Cancer statistics, 2022;Siegel RL;CA Cancer J Clin,2022

2. Thai AA, Solomon BJ, Sequist LV, et al. Lung cancer Lancet. 2021;398:535–54.

3. Non-small cell lung cancer in China;Chen P;Cancer Commun (Lond),2022

4. Histological subtypes of lung cancer in Chinese males from 2000 to 2012;Zou XN;Biomed Environ Sci,2014

5. Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine;Seguin L;Cancers (Basel),2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3